Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › Quest Buys Anatomic Pathology Firm PhenoPath

Quest Buys Anatomic Pathology Firm PhenoPath

Sep 27, 2018
|
staff reporter

NEW YORK (360Dx) – Quest Diagnostics announced today it has acquired specialized anatomic pathology service firm PhenoPath.

The deal, whose terms were not disclosed, continued a buying spree for Quest this week, which included the acquisitions of Oxford Immunotec's US lab business and fertility and fertility diagnostics services firm ReproSource.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In Clinical Lab Management

  1. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

  2. Ortho Clinical Diagnostics COVID-19 Antigen Test Receives FDA EUA for High-Volume Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.